Curious how the Institute for Clinical and Economic Review works? Leslie Isenegger, principal strategist for our Reputation and Risk Management Practice, explains how the organization determines cost and therapeutic effectiveness, assesses the value of orphan drugs, the growing role of the patient in value discussions and more.